tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Narumi Nakagiri, 2 are a BUY (28.57%), 5 are a HOLD (71.43%).
Analyst Narumi Nakagiri, currently employed at DAIWA, carries an average stock price target met ratio of 66.67% that have a potential upside of 8.97% achieved within 72 days.
Narumi Nakagiri’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PFE, Pfizer at 08-Aug-2024.
Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for PFE (PFIZER) at 5/11/2023. The price target of $38 was fulfilled within 33 days with a profit of $2.41 (6.77%) receiving and performance score of 2.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$256
$-6.51 (-2.48%)
$335
19 days ago
(10-Dec-2024)
7/9 (77.78%)
$-19.95 (-7.23%)
593
Buy
$330
$67.49 (25.71%)
$362
1 months 2 days ago
(27-Nov-2024)
10/13 (76.92%)
$50.09 (17.90%)
72
Buy
$380
$117.49 (44.76%)
$345
1 months 17 days ago
(12-Nov-2024)
22/24 (91.67%)
$59.89 (18.71%)
644
Hold
$326
$63.49 (24.19%)
$307
1 months 28 days ago
(31-Oct-2024)
10/11 (90.91%)
$5.84 (1.82%)
83
Buy
$333
$70.49 (26.85%)
$320
2 months 15 days ago
(14-Oct-2024)
25/26 (96.15%)
$8.38 (2.58%)
703
Which stock is Narumi Nakagiri is most bullish on?
What Year was the first public recommendation made by Narumi Nakagiri?
